Home › Grants › United States

Funding programs in United States

Hand-checked programs plus official open data. Each links to its official page. Loans and private funders are labelled.

United States grant list United States funders United States student funding guide

Open-data catalog: Education and training

Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 12 July 2029
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2027
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 3 December 2027
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Advancing Genomic Medicine Research (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Alcohol Research Programs - Training, Individual (Assistance Listing 93.AA3) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Alcohol Research Programs - Training, Institutional (Assistance Listing 93.AA4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Arthritis, Musculoskeletal and Skin Diseases Research - Training Institutional (TI) (Assistance Listing 93.AR4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 16 November 2027
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 September 2027
Bioengineering, Biomedical Imaging, and Technology Development - Other Research (OR) (Assistance Listing 93.EB6) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - Training Individual (TR) (Assistance Listing 93.EB3) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - Training Institutional (TI) (Assistance Listing 93.EB4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Biology of Bladder Cancer (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Biomedical Research - Training, Individual (TR) (Assistance Listing 93.GM3) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Biomedical Research - Training, Institutional (TI) (Assistance Listing 93.GM6) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Biomedical Research and Research Training (Assistance Listing 93.859) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 28 January 2028
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 18 August 2027
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 February 2027
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 28 January 2027
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 June 2027
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 November 2027
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 7 January 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Closes 25 October 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Closes 25 October 2027
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 12 July 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 18 November 2027
Child Health and Human Development Research Training - Individual Awards (Assistance Listing 93.HDD) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Research Training - Institutional Awards (Assistance Listing 93.HDN) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Claude D. Pepper Older Americans Independence Centers · National Institutes of Health · United States (federal) · Forecast
Clinical and Translational Science Award · National Institutes of Health · United States (federal) · Forecast
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Co-infection and Cancer (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 May 2028
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 24 November 2026
Complementary and Integrative Health - Training, Individual (Assistance Listing 93.483) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Complementary and Integrative Health - Training, Institutional (Assistance Listing 93.485) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 April 2027
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 11 August 2027
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 5 November 2026
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 21 August 2028
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Diabetes, Digestive, Kidney Extramural Research - Training, Individual (Assistance Listing 93.KTR) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Diabetes, Digestive, Kidney Extramural Research - Training, Institutional (Assistance Listing 93.KTS) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Drug Use and Addiction Research Programs - Training, Individual (Assistance Listing 93.DA3) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Drug Use and Addiction Research Programs - Training, Institutional (Assistance Listing 93.DA6) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 18 April 2027
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 2 June 2027
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 2 June 2027
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 18 November 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 18 November 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 16 November 2026
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 September 2028
Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Fogarty International Center - Training, Institutional (Assistance Listing 93.TW4) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Forecast to Publish a Notice of Funding Opportunity Announcement for Addressing Determinants of Health Disparities Among Rural Populations (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
Forecast to Publish a Notice of Funding Opportunity for Academic Career Excellence (ACE) Award (K32 - Clinical Trial Required) · National Institutes of Health · United States (federal) · Forecast
Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required) · National Institutes of Health · United States (federal) · Forecast
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 January 2027
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 January 2027
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Health and Extreme Weather Research Coordination and Data Center (U2C - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.